TICKDELTA
Sign in
Screener / SEC EDGAR /CIK 0001944048 /10-K filed Feb 20, 2026, compared with Feb 24, 2025 /Numbers from the XBRL of the 10-Ks
Consumer staples peers:
KVUEKMBHRLHSYCASYEL
NYSE Consumer staples · Cosmetics

Kenvue KVUE

KVUE quote by TradingView

At Kenvue, our purpose is to realize the extraordinary power of everyday care. 10-K, Item 1

Employees
22,000
Headquarters
Summit, NJ
CEO
Kirk Perry
Next results
around Feb 16, 2027
Compare with peers Embed

Where each dollar of revenue went, FY2025

Revenue of $15.1B through the costs to a net profit of $1.5B · income statement of the 10-K

16% operating margin
Revenue to Gross profit: $8.8BRevenue to Cost of revenue: $6.3BGross profit to Operating profit: $2.4BGross profit to Operating expenses: $6.4BOperating profit to Net profit: $1.5BOperating profit to Tax & other: $944.0MOperating expenses to R&D: $382.0MOperating expenses to SG&A: $6.0B Revenue: $15.1B REVENUE $15.1B −2% Y/Y Gross profit: $8.8B · 58% margin GROSS PROFIT $8.8B 58% margin · −2% Y/Y Cost of revenue: $6.3B · 42% of revenue COST OF REVENUE $6.3B 42% of revenue Operating profit: $2.4B · 16% margin OPERATING PROFIT $2.4B 16% margin · +31% Y/Y Operating expenses: $6.4B · 42% of revenue OPERATING EXPENSES $6.4B 42% of revenue Net profit: $1.5B · 10% margin NET PROFIT $1.5B 10% margin · +43% Y/Y Tax & other: $944.0M · 6% of revenue TAX & OTHER $944.0M 6% of revenue R&D: $382.0M · 3% of revenue R&D $382.0M 3% of revenue SG&A: $6.0B · 40% of revenue SG&A $6.0B 40% of revenue
Gross profit $8.8B 58% margin · −2% Y/Y
Operating profit $2.4B 16% margin · +31% Y/Y
Net profit $1.5B 10% margin · +43% Y/Y
The full income statement, year by year

KVUE among Consumer staples peers

Six ratios from the latest 10-K. Each corner is the share of 32 peers the company is above, not a score.

Compare
Revenue growth: -2.1%, above 16% of 32 peers (their median 2.2%) REVENUE GROWTH -2.1% · above 16% Gross margin: 58.3%, above 80% of 30 peers (their median 38.9%) GROSS MARGIN 58.3% · above 80% Operating margin: 17.4%, above 68% of 28 peers (their median 13.6%) OPERATING MARGIN 17.4% · above 68% Net margin: 10.9%, above 59% of 32 peers (their median 7.6%) NET MARGIN 10.9% · above 59% FCF margin: 15.1%, above 66% of 32 peers (their median 10.4%) FCF MARGIN 15.1% · above 66% Return on capital: 9.7%, above 33% of 24 peers (their median 12.3%) RETURN ON CAPITAL 9.7% · above 33%
KVUE Peer median Below the median

What changed

82 new risk paragraphs and 1 accounting fact worth reading about. 10-K filed Feb 20, 2026 against Feb 24, 2025.

Risk factors
82 new paragraphs, nothing like them in the previous 10-K
10-K Item 1A
Receivables growing faster than revenue
Receivables +10.0% vs revenue -2.1% (+12.2 pts)
10-K · XBRL
Accounting checks
10 other checks clear, 1 worth a look
10-K · XBRL
Insiders
No open-market buys in the last 90 days
Form 4
Filings
4 in the last 30 days
EDGAR

Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.

Accounting checks

11 checks on the latest 10-K. Checks, not verdicts.

How it works

1fact worth reading about the other 10 checks found nothing to note

  • Receivables growing faster than revenue
    Receivables +10.0% vs revenue -2.1% (+12.2 pts)
  • Cash from operations $2.2B vs net income $1.5B (FY ending Dec 28, 2025)
9 more checks with nothing to note
  • Inventory +4.7% vs revenue -2.1% (+6.9 pts)
  • Same auditor in both 10-Ks: PricewaterhouseCoopers LLP
  • No statement of substantial doubt about going concern
  • No 8-K item 4.02 in the last 2 years
  • No NT 10-K or NT 10-Q in the last 2 years
  • The same matters as last year: Revenue Recognition - U.S. Net Sales
  • No sentence in the 10-K concludes that controls were not effective because of a material weakness
  • No 8-K item 2.06 in the last 2 years
  • No 8-K item 1.03 in the last 2 years

In their words

82 paragraphs in Risk Factors that were not in the 10-K filed Feb 24, 2025. Quoted as filed.

All 82 new paragraphs
  1. Item 1A · new paragraph · not in the 10-K filed Feb 24, 2025 10-K, ITEM 1A
    If the Proposed Transaction is consummated, the combined company may not perform as we or the market expects and may fail to realize the projected benefits and cost savings of the Proposed Transaction, which could adversely affect the value of K-C common stock, which our shareholders will own following the completion of the Proposed…
  2. Item 1A · new paragraph · not in the 10-K filed Feb 24, 2025 10-K, ITEM 1A
    Pursuant to the Merger Agreement, we are subject to certain contractual limitations on acquisitions and divestitures prior to the closing of the Proposed Transaction. These restrictions may limit our ability to execute aspects of our growth strategy or portfolio optimization initiatives until the Proposed Transaction closes. See “—Risks…
  3. Item 1A · new paragraph · not in the 10-K filed Feb 24, 2025 10-K, ITEM 1A
    The manufacturing and distribution of our products involves a variety of raw materials, including resins, silicon, pulp and corn derivatives, paper, agrochemicals, vegetable oils and oleochemicals; and other inputs, including energy, labor, transportation
  4. Item 1A · new paragraph · not in the 10-K filed Feb 24, 2025 10-K, ITEM 1A
    From time to time we implement restructuring or strategic initiatives intended to maintain long-term sustainable growth, such as the recently announced restructuring initiative (as described in Note 20, “Subsequent Events,” to the Consolidated Financial

New risk paragraphs, against peers

Latest 10-K of each, Consumer staples companies closest in revenue

Paragraphs in Risk Factors with nothing like them in the company's 10-K the year before. A count of text, not of risk.

Financial performance

Last 4 fiscal years · 10-K XBRL

All years
MetricFY2022FY2023FY2024FY2025
Revenue$14.9B$15.4B$15.5B$15.1B
Net income$2.1B$1.7B$1.0B$1.5B
Operating cash flow$2.5B$3.2B$1.8B$2.2B
Free cash flow$2.1B$2.7B$1.3B$1.7B

Revenue, FY2021 to FY2025

Ten fiscal years, each from its own 10-K · XBRL · USD

$15.1B ▼ 2.1% in FY2025

FY2021FY2022FY2023FY2024FY2025
Every number, year by year

Recent filings

4 filings in the last 30 days · SEC EDGAR

All filings

About the company

Kenvue, Summit, NJ · from the 10-K filed Feb 20, 2026

At Kenvue, our purpose is to realize the extraordinary power of everyday care. As a global leader at the intersection of healthcare and consumer goods, we are the world’s largest pure-play consumer health company by revenue with $15.1 billion in Net sales in the fiscal year 2025. By combining the power of science with meaningful consumer insights and our digital strategy, we empower consumers to live healthier lives every day.

Headquarters
Summit, NJ
Country
United States
Reports in
USD
Listed on
NYSE
Fiscal year ends
January 3
Last results
Oct 30, 2026
Incorporated in
DE

Employees, at the top of the page: "As of December 28, 2025, we had approximately 22,000 employees, with approximately 23% located in North America, 28% in EMEA, 30% in APAC, and 19% in LATAM" (10-K). Address and exchange: SEC's company file.

Email alerts

Sources

The 10-K filed Feb 20, 2026 (open at SEC), compared with the 10-K filed Feb 24, 2025. Numbers from the XBRL of the 10-Ks; filings from SEC EDGAR.

Work with it: Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/KVUE/export.csv") into a cell.